Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zymeworks (ZYME) EPS (Basic) (2021 - 2025)

Zymeworks' EPS (Basic) history spans 5 years, with the latest figure at -$0.55 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 71.87% to -$0.55 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.08, a 33.33% increase, with the full-year FY2025 number at -$1.08, up 33.33% from a year prior.
  • EPS (Basic) hit -$0.55 in Q4 2025 for Zymeworks, down from -$0.26 in the prior quarter.
  • Over the last five years, EPS (Basic) for ZYME hit a ceiling of $4.77 in Q4 2022 and a floor of -$1.18 in Q1 2022.
  • Historically, EPS (Basic) has averaged -$0.25 across 5 years, with a median of -$0.42 in 2023.
  • Biggest five-year swings in EPS (Basic): soared 727.63% in 2022 and later plummeted 103.98% in 2023.
  • Tracing ZYME's EPS (Basic) over 5 years: stood at -$0.76 in 2021, then soared by 727.63% to $4.77 in 2022, then plummeted by 103.98% to -$0.19 in 2023, then plummeted by 68.42% to -$0.32 in 2024, then tumbled by 71.87% to -$0.55 in 2025.
  • Business Quant data shows EPS (Basic) for ZYME at -$0.55 in Q4 2025, -$0.26 in Q3 2025, and $0.03 in Q2 2025.